COVID-19

Overview

At the end of December 2019, Chinese public health authorities reported several cases of acute respiratory syndrome in Wuhan City, Hubei province, China. Chinese scientists soon identified a novel coronavirus as the main causative agent. The disease is now referred to as coronavirus disease 2019 (COVID-19), and the causative virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is a new strain of coronavirus that has not been previously identified in humans.

The initial outbreak in Wuhan spread rapidly, affecting other parts of China. Cases were soon detected in several other countries. Outbreaks and clusters of the disease have since been observed in Asia, Europe, Australia, Africa and the Americas.

For a quick overview, please refer to the following pages:

 

The COVID-19 pandemic is rapidly evolving, and outbreak investigations are ongoing. ECDC is closely monitoring this outbreak, providing risk assessments, public health guidance, and advice on response activities to EU Member States and the EU Commission.

Latest updates

Publication

Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK– ninth update

Risk assessment -

Data

Download today’s data on the geographic distribution of COVID-19 cases worldwide

Table -

Publication

Contact tracing for COVID-19: current evidence, options for scale-up and an assessment of resources needed

Technical report -

Publication

Communicable disease threats report, 26 April-2 May 2020, week 18

Publication -

Publication

Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - First update

Technical report -

Situation update 6 May 2020, dataset collected 6:00-10:00 CET

3 623 803 cases
Worldwide
256 880 deaths
Whereof 139 750 deaths in the EU/EEA and UK
1 186 111 cases
in the EU/EEA and the UK.